Screener
Whitehawk Therapeutics WHWK Q2 2026 earnings
Reported August 6, 2026 · Before market open
EPS-$0.20Beat by $0.10
Revenue estimate-$350.0K
EPS estimate-$0.30
Next report
Nov 5, 2026 (in 2 months)EPS estimate-$0.27
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Whitehawk Therapeutics report Q2 2026 earnings?
- Whitehawk Therapeutics (WHWK) reported Q2 2026 earnings on August 6, 2026 before market open.
- What were Whitehawk Therapeutics's Q2 2026 revenue and EPS?
- Whitehawk Therapeutics reported eps of $-0.20 for Q2 2026.
- Did Whitehawk Therapeutics beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-0.30 by $0.10.
- How did Whitehawk Therapeutics's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 73.7% from $-0.76.
- Where can I find Whitehawk Therapeutics's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-337069) and the 10-Q periodic report (0001193125-26-337933) directly on SEC EDGAR. The filing index links above go to sec.gov.
